White Paper

Manufacturing Process Scale-up For Phase III

Source: Thermo Fisher Scientific

By Sanjay Konagurthu, PhD, Senior Director, Science and Innovation, Thermo Fisher Scientific; John W. Burke, Manager of Pharmaceutical Process Technologies, Steriles, Thermo Fisher Scientific

Manufacturing Process Scale-up For Phase III

Your compound has been progressing well through small-scale studies. The data collected in early trials suggest the formulation is safe and has great potential for improving its intended target condition. Critical make-or-break Phase III studies are on the horizon to demonstrate safety and efficacy in large numbers of patients. Is your team ready to manufacture larger batch sizes to support this endeavor? Possibly.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: